week 19 pt2 Flashcards
- Define apoptosis
programmed cell death
That plays in the role of developmental morphogens and eliminate damage cells
Evasion of apoptosis is one of hallmark of cancer
How is the process of apoptosis
- Shrink
- Develop bubble like blebs
- Chromatin degrades
- Mitochondria break up releasing cytochrome
- Cells break in the membrane wrapped fragments
- Phosphatidylserine is exposed on surface which promotes phagocytosi
- Cell fragments are removed by phagocytosis
Why is Apoptosis is used to remove cells that are a threat
- Cells need be eliminated sometimes
- Infected cells are killed by cytotoxic T cells
- Removal of immune infections
- Cells that have dna dmage
How can apoptosis occurs
- Can occur two ways
- Intrinsic pathway: internal signal such DNA damager and oxidative damage
Or extinctic e pathway, extrinsic signal such as death factors
Why does caspases play a vital role in apoptosis
Have proteases that act like molecular scissors to cleave intracellular protein
Vital in both pathways
Caspases activate procaspases that lead to apoptic signals.
pathways of extristic
FAS-LIG FAS-R FADD DISC CASP CASP3 NUCLESE CELL. DEATH
Intrinsic pathway
DNA DAMAGE ATM P53 BOL-BAD BOX-BAK CYTOCHROME APAF 1 CASPASE 9
What causes cancer through apoptosis
- Bcl-2 protein need to be balancez
- Bcl-2 is an oncogene overexpression in neuroblastoma, giloma
- Bax isd muatate din colorrectyal cancer
- Death signals and death receptors expression can be reduced
- So cannot be exposed to death domain
How does caspase promote cancer
- Caspases are downregulated
- Caspase 9 in colorectal cancer
- Caspase in 8 and 10 choriocarcinoma
Resistance to chemotherapy
How does P53 effect apoptosis
- P53 induce apotosais in response to DNA ddmaage and cellular stress
- Does this. By trnasciption dpoendent and indpendend.
- P53 induce death receptor and pro-apopotic members of the Bcl-2 family.
How does P53 mess up to cause cancer
• P53 upsets the balance of Bcl-2 and Bax proteins that regulate the release of cytochrome c
Binds with Bax to activate
It represses Bcl-2
Also activates death ligand Fas
What are the treatment to target intrinsic pathway in apoptosis
BH3 mimetics – small molecules that act like BH3-only proteins to inhibit Bcl-2 – some in phase 2 clinical trials e.g. venetoclax (FDA approved).
Resistance can develop due to Bcl-2 or P53 mutations.
IAP inhibitors – eg small molecules that mimic the endogenous inhibitor SMAC
What are the treatment to target extrinsic pathway in apoptosis
TRAIL (TNF- related apoptosis inducing ligand the ligand for DR4 and DR5 is normally expressed on immune cells.
Agonists (agents that increase activity) targeting this pathway are currently in Phase I and II clinical trials.
How to prevent resistance
- cFLIP is a common mediator of resistance to these drugs
- Common chemotherapies can down regulate FLIP
Most trials now using combination approaches
How can inhibition of extristic pathway be inhibnited
by the protein c-FLIP
C-Flip binds to FADD and TRADD via a DED
Inhibits caspase 8 recruitment and activation.